Showing results (101-110 of 327) with videos related to
Sort By:
Pageof 33
Postgraduate Medicine|July 26, 2008
Schizophrenia, obesity, and antipsychotic medications: what can we do?Leslie Citrome, Betty VreelandExpert Opinion on Pharmacotherapy|June 30, 2009
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-makingJan Volavka, Leslie CitromeExpert Opinion on Drug Safety|November 6, 2008
Olanzapine: review of safety 2008Joshua T Kantrowitz, Leslie CitromeThe Western Journal of Emergency Medicine|March 15, 2016
Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency SettingScott L Zeller, Leslie CitromeExpert Opinion on Pharmacotherapy|October 25, 2011
On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does notLeslie Citrome, Henry A NasrallahClinical Pharmacokinetics|October 11, 2016
Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published LiteratureWilliam M Greenberg, Leslie CitromeClinical Therapeutics|September 19, 2019
Disclosures and Conflicts of Interest: Solving the Riddle, Wrapped in a Mystery, Inside an EnigmaLisa M DeTora, Leslie CitromeThe Journal of Clinical Psychiatry|February 21, 2020
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and TreatmentLeslie Citrome, Stephen R SakladThe Psychiatric Quarterly|October 24, 2007
Reducing inpatient aggression: does paying attention pay off?Karen A Nolan, Leslie CitromeNeurology and Therapy|December 15, 2015
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical EvidenceWilliam M Greenberg, Leslie CitromePageof 33